Pharmerica Corp (PMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,800 | 13,500 | 15,400 | 5,400 | 6,500 |
| Receivables | 254,300 | 253,200 | 252,800 | 240,100 | 224,100 |
| Inventories | 139,200 | 139,600 | 143,500 | 214,700 | 118,800 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 26,300 |
| TOTAL | $455,300 | $457,400 | $468,800 | $516,700 | $430,000 |
| Non-Current Assets | |||||
| PPE Net | 89,300 | 88,300 | 87,100 | 85,800 | 84,600 |
| Intangibles | 642,700 | 610,500 | 611,500 | 579,900 | 559,500 |
| Other Non-Current Assets | 81,100 | 80,500 | 84,900 | 90,600 | 83,400 |
| TOTAL | $813,100 | $779,300 | $783,500 | $756,300 | $727,500 |
| Total Assets | $1,268,400 | $1,236,700 | $1,252,300 | $1,273,000 | $1,157,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 15,400 | 15,500 | 15,500 | 15,600 | 11,800 |
| Accounts payable and accrued liabilities | 97,100 | 104,500 | 86,900 | 107,100 | 73,000 |
| Accrued Expenses | 34,800 | 31,600 | 34,000 | 32,500 | 28,200 |
| TOTAL | $176,300 | $177,800 | $161,200 | $182,300 | $138,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 444,800 | 417,400 | 451,000 | 457,800 | 378,700 |
| Other Non-Current Liabilities | 85,700 | 84,700 | 89,700 | 88,700 | 91,200 |
| TOTAL | $530,500 | $502,100 | $540,700 | $546,500 | $483,200 |
| Total Liabilities | $706,800 | $679,900 | $701,900 | $728,800 | $621,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,120 | 31,121 | 31,095 | 30,790 | 30,782 |
| Common Shares | 300 | 300 | 300 | 300 | 300 |
| Retained earnings | 185,100 | 181,900 | 177,200 | 173,700 | 166,000 |
| Other shareholders' equity | -100 | -100 | -100 | 100 | 100 |
| TOTAL | $561,600 | $556,800 | $550,400 | $544,200 | $535,800 |
| Total Liabilities And Equity | $1,268,400 | $1,236,700 | $1,252,300 | $1,273,000 | $1,157,500 |